retatrutide clinical trial results obesity Incretin triple agonist (LY3437943) alleviates obesity-associated cancer progression Lilly's triple agonist achieves 16.8%

Physiol Behav

Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation

Pair the Home 2 Suspension Trainer with the TRX App, streaming 24/7 from your phone, tablet, or TV for advanced strength training at home, outside, or in the gym. What You Get: THE GLP-1 STRENGTH PROGRAM Led by nurse practitioner and certified trainer Lisa Witzlib, this beginner-friendly 4-week program combines Suspension Training with medical expertise to help you counteract muscle loss associated with GLP-1 medications

Sauv doesn't think that's an accident

Years of real-world evidence across millions of patients